Evidence map›Paper›PMID 30976672›Full record

ArticleHeliyon2019

Prabhakar Yellanur Konda, Sreenivasulu Dasari, Sreenath Konanki, Prabhusaran Nagarajan

Open access · goldAbstract read
In one paragraph

Article in Heliyon, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
3.3field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 30 citations in OpenAlex.

  1. Article
  2. Article
  3. Potential Effect of Curcumin in Lowering Blood Glucose Level in Streptozotocin-Induced Diabetic Rats.Diabetes, metabolic syndrome and obesity : targets and therapy · 2024
    Article
  4. Article
  5. The effect ofJournal of diabetes and metabolic disorders · 2022
    Article
  6. Review
  7. Roles ofPlants (Basel, Switzerland) · 2022
    Review
  8. Article
  9. Article
  10. The effect ofHeliyon · 2021
    Article
  11. Article
  12. Article
  13. Antidiabetic Potential ofThe Yale journal of biology and medicine · 2020
    Review
  14. Journal of diabetes and metabolic disorders · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 4 institutions in 1 country.

Prabhakar Yellanur KondaBiochemistry Division, National Institute of Nutrition, Hyderabad 500007, India.
Sreenivasulu DasariDepartment of Biochemistry, Sri Venkateswara University, Tirupati 517502, India.
Sreenath KonankiDepartment of Biotechnology, Sri Krishnadevaraya University, Anantapur 515003, India.
Prabhusaran NagarajanDepartment of Microbiology, Trichy SRM Medical College Hospital and Research Centre, Tiruchirapalli 621 105, India.
National Institute of Nutrition · INSri Krishnadevaraya University · INSri Venkateswara University · INTrichy SRM Medical College Hospital and Research Centre · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Abnormal glucose metabolism causes various complications in many metabolic diseases such as obesity, hypertension, cardiovascular diseases and mainly diabetes. But commonly used oral hypoglycemic drugs cause severe side effects. Hence, there is a need to find the medicine without side effects. Compounds of medicinal plants were nontoxic, inexpensive and less or no side effects.

Indexed as

BiochemistryCell biologySystems biology

Identifiers

PMID30976672
PMCPMC6441845
OpenAlexW2924333796

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.